5.0
Aug 16, 2021
Recommend
CEO approval
Business Outlook
Pros
Experienced Leadership - Have taken this company from zero to current 6 clinical molecules in little more than 5 years.
Cons
Covid has been stressful for everyone, but company has handled it very well.